Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.

Publication date: May 08, 2023

Open Access PDF

Concepts Keywords
Antibodies Anti
Controversial Antibodies
Coronavirus Antibody
Morocco Assessed
Cov
Iga
Igg
Igm
Kinetics
Onset
Rbd
Sars
Symptom
Year

Semantics

Type Source Name
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease VO Severe acute respiratory syndrome coronavirus 2
disease IDO blood
disease IDO assay
disease IDO symptom
disease VO time
disease VO vaccine
disease MESH infection
disease VO unvaccinated
disease MESH Vector Borne Diseases
disease MESH Hepatitis
disease MESH pneumonia
disease MESH viral infections
drug DRUGBANK Angiotensin II
drug DRUGBANK Indoleacetic acid
disease VO Glycoprotein
disease MESH convalescence
disease IDO production
disease MESH reinfection
disease IDO host
disease VO vaccination
disease VO population
disease VO protocol
disease VO D15
disease VO vaccinated

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *